icon-folder.gif   Conference Reports for NATAP  
  The International Liver Congress™
EASL 2017 - European Association for the
Study of the Liver
Amsterdam, The Netherlands. 2017
Back grey_arrow_rt.gif
A pilot study for safety and efficacy of 12 weeks sofosbuvir plus daclatasvir with or without ribavirin in egyptian adolescents with chronic hepatitis C virus Infection
  Reported by Jules Levin
EASL 2017 April 19-23 Amsterdam Netherlands
Manal El-Sayed* 1, Mohamed Hassany2, Noha Asem3
1Department of Pediatrics, Faculty of Medicine,Ain Shams University, 2Tropical Medicine Department , National Hepatology & Tropical Medicine Research Institute, 3Public Health Department , Faculty of Medicine , Cairo University, Cairo, Egypt